Diabetes medication shows promise in cutting migraine days by more than half
A diabetes drug that reduces brain fluid pressure, the European Academy of Neurology (EAN) Congress has cut more than half in monthly migraine days, according to a new study presented in 2025 today. Researchers gave “Federico II” at the headache center of Naples University GlucagonFor such as Peptide -1 (GLP -1) receptor agonist liraglutide 26 […]